LENZ Therapeutics
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. over the previous period. Total operating expenses were $70,703,000.
Profit Margin
| 2019 | 0 | -109K | |
|---|---|---|---|
| 2020 | 0 | -68.37M | |
| 2021 | 0 | -70.76M | |
| 2022 | 15M | -101.05M | -673.68% |
| 2023 | 0 | -124.65M |
LENZ Income Statement (2019 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
Revenue | |||||
Revenue | 0 | 15M | 0 | 0 | 0 |
Cost of revenue | 2.40M | 8.34M | 734K | 121K | 0 |
Gross profit | -2.40M | 6.65M | -734K | -121K | 0 |
Operating exp. | |||||
Research and development | 29.73M | 64.44M | 37.93M | 9.12M | 0 |
Selling and marketing | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 70.70M | 97.29M | 59.70M | 13.37M | 29K |
Operating income | -73.11M | -105.63M | -60.44M | -13.5M | -29K |
Other income (expenses), net | -51.54M | 4.58M | -10.31M | -54.87M | -80K |
Income before tax | -124.65M | -101.05M | -70.76M | -68.37M | -109K |
Income tax expense | -124.65M | 347K | 0 | 0 | 0 |
Net income | -124.65M | -101.05M | -70.76M | -68.37M | -109K |
Earnings per share | |||||
Basic EPS | -15.3 | -4.3 | -2.85 | -8.24 | -0.01 |
Diluted EPS | -15.3 | -4.3 | -2.85 | -8.24 | -0.01 |